AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zelira Therapeutics Ltd

0.420

0.000

Volume:602.00

Turnover:253.00

Market Cap:5.00M

PE:-0.98

High:0.420

Open:0.420

Low:0.420

Close:0.420

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Zelira Therapeutics Ltd

Exchange:

ASX

Establishment Date:

2003

Employees:

- -

Office Location:

101 St Georges Terrace,Level 3,Perth,Western Australia,Australia

Website:

http://www.zeliratx.com

Zip Code:

6000

Phone:

Fax:

61 8 6316 3337

Introduction:

Zelira Therapeutics Limited, a bio-pharmaceutical company, develops cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and opioid reduction; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer, as well as the potential for cannabinoid formulations to treat diabetes-associated cognitive decline. It has a strategic partnership with CannPal Pty Ltd.; and St Vincent's Hospital on opioid reduction study. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited is based in Perth, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ZLD.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ZLD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZLD.AU\",,,,,undefined,":{"symbol":"ZLD.AU","market":"AU","secType":"STK","nameCN":"Zelira Therapeutics Ltd","latestPrice":0.42,"timestamp":1752819120000,"preClose":0.42,"halted":0,"volume":602,"delay":0,"nameEN":"Zelira Therapeutics Ltd","floatShares":6436754,"shares":11897155,"eps":-0.426952,"marketStatus":"Market Closed","change":0,"latestTime":"07-18 16:12:00 AEST","open":0.42,"high":0.42,"low":0.42,"amount":253,"amplitude":0,"askPrice":0.46,"askSize":400,"bidPrice":0.42,"bidSize":2752,"shortable":3,"etf":0,"ttmEps":-0.426952,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1753056000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.42,"openAndCloseTimeList":[[1752796800000,1752818400000]],"volumeRatio":0.3644950174620965,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZLD.AU\",,,,,undefined,":{"symbol":"ZLD.AU","floatShares":6436754,"roa":"-92.11%","roe":"-266.82%","lyrEps":-3.222737,"volumeRatio":0.3644950174620965,"shares":11897155,"dividePrice":0,"high":0.42,"amplitude":0,"preClose":0.42,"low":0.42,"week52Low":0.345,"pbRate":"-0.59","psRate":"122.22","week52High":0.92,"institutionHeld":0,"latestPrice":0.42,"committee":0.746193,"eps":-0.426952,"divideRate":0,"volume":602,"delay":0,"ttmEps":-0.426952,"open":0.42,"prevYearClose":0.62,"prevWeekClose":0.42,"prevMonthClose":0.44,"prevQuarterClose":0.44,"fiveDayClose":0.42,"twentyDayClose":0.45,"sixtyDayClose":0.35},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":318884570,"yearFounded":2003,"address":"101 St Georges Terrace,Level 3,Perth,Western Australia,Australia","zipCode":"6000","officePhone":"61 8 6558 0886","officeFax":"61 8 6316 3337"},"stockCompanyDetail":{"websiteUrl":"http://www.zeliratx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0769},{"period":"6month","weight":-0.3333},{"period":"1year","weight":-0.4545},{"period":"ytd","weight":-0.3226}],"compareEarnings":[{"period":"1week","weight":0.0051},{"period":"1month","weight":0.0141},{"period":"3month","weight":0.0788},{"period":"6month","weight":0.1393},{"period":"1year","weight":0.2056},{"period":"ytd","weight":0.1562}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Zelira Therapeutics Limited, a bio-pharmaceutical company, develops cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and opioid reduction; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer, as well as the potential for cannabinoid formulations to treat diabetes-associated cognitive decline. It has a strategic partnership with CannPal Pty Ltd.; and St Vincent's Hospital on opioid reduction study. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited is based in Perth, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.065842},{"month":2,"riseRate":0.111111,"avgChangeRate":0.07074},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.038577},{"month":4,"riseRate":0.444444,"avgChangeRate":0.14967},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.123061},{"month":6,"riseRate":0.666667,"avgChangeRate":0.338889},{"month":7,"riseRate":0.5,"avgChangeRate":-0.052914},{"month":8,"riseRate":0.5,"avgChangeRate":0.001297},{"month":9,"riseRate":0.25,"avgChangeRate":-0.047775},{"month":10,"riseRate":0.5,"avgChangeRate":0.056461},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.036189},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.001787}],"exchange":"ASX","name":"Zelira Therapeutics Ltd","nameEN":"Zelira Therapeutics Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ZLD.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZLD.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2022-04-14","symbol":"ZLD.AU","defaultRemindTime":1649894400000,"type":"split","dateTimestamp":1649858400000,"forFactor":175,"toFactor":1,"ratio":175}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZLD.AU\",market:\"AU\",,,undefined,":[]}}